TRIMU 5
From Wikipedia, the free encyclopedia
TRIMU 5 | |
---|---|
IUPAC name L-tyrosyl-N-{[(3-methylbutyl)amino]acetyl}-D-alaninamide | |
Other names (2S)-2-amino-3-(4-hydroxyphenyl)-N-[(2R)-1-{[2-(3-methylbutylamino)acetyl]amino}-1-oxopropan-2-yl]propanamide | |
Identifiers | |
CAS number | 90815-77-3 |
PubChem | 5487273 |
ChemSpider | 21106389 |
Jmol-3D images | {{#if:Oc1ccc(C[C@@H](N)C(=O)N[C@H](C)C(=O)NC(=O)CNCCC(C)C)cc1|Image 1 |
| |
| |
Properties | |
Molecular formula | C19H30N4O4 |
Molar mass | 378.466 |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
TRIMU 5 is a selective agonist of the mu-2 mu opioid receptor.[1]
References
- ↑ Eisenberg RM (1994). "TRIMU-5, a mu 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis". Pharmacol. Biochem. Behav. 47 (4): 943–6. doi:10.1016/0091-3057(94)90300-X. PMID 8029266.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.